Physical and functional association of the major histocompatibility complex class I heavy chain α3 domain with the transporter associated with antigen processing

Journal of Experimental Medicine

Volumn 187, Issue 6, 1998, Pages 865-874

  Kulig, Kimary ^a   Nandi, Dipankar ^b   Bačík, Igor ^c   Monaco, John J ^d   Vukmanović, Stanislav ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b INDIAN INSTITUTE OF SCIENCE   (India)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD8 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

AMINO ACID SUBSTITUTION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; BINDING SITE; GENE SEQUENCE; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; BETA 2-MICROGLOBULIN; H-2 ANTIGENS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MUTATION; STRUCTURE-ACTIVITY RELATIONSHIP; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032536790     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.6.865     Document Type: Article

References (48)

1. Schumacher, T.N.M., M.-T. Heemels, J.J. Neefjes, W.M. Kast, C.J.M. Melief, and H.L. Ploegh. 1990. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell. 62:563-567.
2. Townsend, A., C. Ohlen, J. Bastin, H.-G. Ljungren, L. Foster, and K. Karre. 1989. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature. 340:443-448.
3. b molecule. Nature. 348:213-216.
4. Falk, K., O. Rotzschke, S. Stevanovic, G. Jung, and H.-G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature. 351:290-296.
5. Tector, M., and R.D. Salter. 1995. Calnexin influences folding of human class I histocompatibility proteins but not their assembly with beta 2-microglobulin. J. Biol. Chem. 270: 19638-19642.
6. Vasillakos, A., M. Cohen-Doyle, P.A. Peterson, M.R. Jackson, and D.B. Williams. 1996. The molecular chaperone calnexin facilitates folding and assembly of class I histocompatibility molecules. EMBO (Eur. Mol. Biol. Organ.) J. 15:1495-1506.
7. Shepherd, J.C., T.N.M. Schumacher, P.G. Ashton-Rickardt, S. Imaeda, H.L. Ploegh, C.A. Janeway, and S. Tonegawa. 1993. TAP1-dependent peptide translocation in vitro is ATP-dependent and peptide selective. Cell. 74:577-584.
8. Neefjes, J.J., F. Momburg, G.J. Hammerling. 1993. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science. 261:769-771.
9. Suh, W.-K., M.F. Cohen-Doyle, K. Fruh, K. Wang, P.A. Peterson, and D.B. Williams. 1994. Interaction of MHC class I molecules with the transporter associated with antigen processing. Science. 264:1322-1326.
10. Ortmann, B., M. Androlewicz, and P. Cresswell. 1994. MHC class I/β2-microglobulin complexes associate with TAP transporters before peptide binding. Nature. 368:864-867.
11. Carreno, B.M., J.C. Solheim, M. Harris, I. Stroynowski, J.M. Connolly, and T.H. Hansen. 1995. TAP associates with a unique class I conformation, whereas calnexin associates with multiple class I forms in mouse and man. J. Immunol. 155: 4726-4733.
12. Androlewicz, M.J., B. Ortmann, P.M. van Endert, T. Spies, and P. Cresswell. 1994. Characteristics of peptide and major histocompatibility complex class I/β2-microglobulin binding to the transporters associated with antigen processing (TAP1 and TAP2). Proc. Natl. Acad. Sci. USA. 91:12716-12720.
13. Shimizu, Y., and R. Demars. 1989. Production of human cells expressing individual transferred HLA-A, -B, -C genes using and HLA-A, -B, -C null human cell line. J. Immunol. 142:3320-3328.
14. Grandea, A.G.I., M.J. Androlewic, R.S. Athwal, D.E. Geraghty, and T. Spies. 1995. Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science. 270:105-108.
15. Sadasivan, B., P.J. Lehner, B. Ortmann, T. Spies, and P. Cresswell. 1996. Roles of calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity. 5:103-114.
16. Li, S., H.-O. Sjogren, U. Hellman, R.F. Pettersson, and P. Wang. 1997. Cloning and functional characterization of a subunit of the transporter associated with antigen processing. Proc. Natl. Acad. Sci. USA. 94:8708-8713.
17. Ortmann, B., J. Copeman, P.J. Lehner, B. Sadasivan, J.A. Herberg, A.G.I. Grandea, S.R. Riddell, R. Tampe, T. Spies, J. Trowsdale, and P. Cresswell. 1997. A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. Science. 277:1306-1309.
18. Solheim, J.C., M.R. Harris, C.S. Kindle, and T.H. Hansen. 1997. Prominence of β2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing. J. Immunol. 158:2236-2241.
19. Wei, M., and P. Cresswell. 1992. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature. 356:443-446.
20. Henderson, R.A., H. Michel, K. Sakaguchi, J. Shabanowitz, E. Appella, D.F. Hunt, and V.H. Engelhard. 1992. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science. 255:1264-1266.
21. Hughes, E., C. Hammond, and P. Cresswell. 1997. Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc. Natl. Acad. Sci. USA. 94:1896-1901.
22. Suh, W.-K., E.K. Mitchell, Y. Yang, P.A. Peterson, G.L. Waneck, and D.B. Williams. 1996. MHC class I molecules form ternary complexes with calnexin and TAP and undergo peptide-regulated interaction with TAP via their extracellular domains. J. Exp. Med. 184:337-348.
23. Lee, N., A.R., Malacko, A. Ishitani, M.-C. Chen, J. Bajorath, H. Marquardt, and D.E. Geraghty. 1995. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity. 3:591-600.
24. Potter, T.A., T.V. Rajan, R.F. Dick II, and J.A. Bluestone. 1989. Substitution at residue 227 of H-2 class I molecules abrogates recognition by CD8-dependent, but not CD8-independent, cytotoxic T lymphocytes. Nature. 337:73-75.
25. Connoly, J., T.H. Hansen, A.L. Ingold, and T.A. Potter. 1990. Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I α3 domain: CD8 and the T-cell receptor recognize the same class I molecule. Proc. Natl. Acad. Sci. USA. 87:2137-2141.
26. Killeen, N., A. Moriarty, H.-S. Teh, and D.R. Littman. 1992. Requirement for CD8-major histocompatibility complex class I interaction in positive and negative selection of developing T cells. J. Exp. Med. 176:89-97.
27. Williams, D.B., B.H. Barber, R.A. Flavell, and H. Allen. 1989. Role of β2-microglobulin in the intracellular transport and surface expression of murine class I histocompatibility molecules. J. Immunol. 142:2796-2806.
28. Vitiello, A., T.A. Potter, and L.A. Sherman. 1990. The role of β2-microglobulin in peptide binding by class I molecules. Science. 250:1423-1426.
29. Attaya, M., S. Jameson, C.K. Martinez, E. Hermel, C. Aldrich, J. Forman, K. Fischer-Lindahl, M.J. Bevan, and J.J. Monaco. 1992. Ham-2 corrects the class I antigen processing-defect in RMA-S cells. Nature. 355:647-649.
30. Spies, T., V. Cerundolo, M. Collona, P. Cresswell, A. Townsend, and R. DeMars. 1992. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature. 355:644-646.
31. b molecule using a retroviral shuttle vector. Immunogenetics. 34:62-65.
32. + T cells from β2-microglobulin-deficient (β2m-/-) mice to syngeneic β2m+/+ cells. J. Immunol. 154:6252-6261.
33. Eisenlohr, L.C., I. Bačík, J.P. Bennink, K. Bernstein, and J.W. Yewdell. 1992. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes. Cell. 71:963-972.
34. Bačík, I., J.H. Cox, R. Anderson, J.W. Yewdell, J.R. Bennink. 1994. TAP-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences when located at the amino but not carboxy terminus of the peptide. J. Immunol. 152:381-387.
35. Chakrabarti, S., K. Brechling, B. Moss. 1985. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403-3409.
36. Brown, M.G., J. Driscoll, and J.J. Monaco. 1991. Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes. Nature. 353: 355-357.
37. Nandi, D., E. Woodward, D.B. Ginsburg, and J.J. Monaco. 1997. Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor β subunits. EMBO (Eur. Mol. Biol. Organ.) J. 16:5363-5375.
38. Machold, R.P., S. Andree, L. Van Kaer, H.-G. Ljunggren, and H.L. Ploegh. 1995. Peptide influences the folding and intracellular transport of free major histocompatibility complex class I heavy chains. J. Exp. Med. 181:1111-1122.
39. Brown, J.H., T.S. Jardetzky, J.C. Gorga, J.C. Stern, R.G. Urban, J.L. Strominger, and D.C. Wiley. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 364:33-39.
40. Bjorkman, P.J., M.A. Saper, B. Samraoui, W.S. Bennett, J.L. Strominger, and D.C. Wiley. 1987. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 329: 506-512.
41. Anderson, K., P. Cresswell, M. Gammon, J. Hermes, A. Williamson, and H. Zweerink. 1991. Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis. J. Exp. Med. 174:489-492.
42. Eisenlohr, L.C., J.W. Yewdell, and J.R. Bennink. 1992. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med. 175:481-487.
43. Neisig, A., R. Wubbolts, X. Zang, C. Melief, and J. Neefjes. 1996. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J. Immunol. 156:3196-3206.
44. Ooba, T., H. Hayashi, S. Karaki, M. Tanabe, K. Kano, and M. Takiguchi. 1989. The structure of HLA-B35 suggests that it is derived from HLA-Bw58 by two genetic mechanisms. Immunogenetics. 30:76-80.
45. Koziel, M.J., D. Dudley, J.T. Wong, J. Dienstag, M. Houghton, R. Ralston, and B.D. Walker. 1992. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J. Immunol. 149:3339-3344.
46. Lewis, J.W., A. Neisig, J. Neefjes, and T. Elliott. 1996. Point mutations in the a2 domain of HLA-A2.1 define a functionally relevant interaction with TAP. Curr. Biol. 6:873-883.
47. Peace-Brewer, A.L., L.G. Tussey, M. Matsui, G. Li, D.G. Quinn, and J.A. Frelinger. 1996. A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL. Immunity. 4:505-514.
48. Elliott, T. 1997. How does TAP associate with MHC class I molecules. Immunol. Today. 18:375-379.